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Abstract
Dietary v-3 polyunsaturated fatty acids (PUFAs) decrease cardiovascular risk via suppression of inflammation. The
generation of electrophilic a,b-unsaturated ketone derivatives of the v-3 PUFAs docosahexaenoic acid (DHA) and
docosapentaenoic acid (DPA) in activated human macrophages is catalyzed by cyclooxygenase-2 (Cox-2). These derivatives
are potent pleiotropic anti-inflammatory signaling mediators that act via mechanisms including the activation of Nrf2-
dependent phase 2 gene expression and suppression of pro-inflammatory NF-kB-driven gene expression. Herein, the
endogenous generation of v-3 PUFAs electrophilic ketone derivatives and their hydroxy precursors was evaluated in human
neutrophils. In addition, their dietary modulation was assessed through a randomized clinical trial.
Methods: Endogenous generation of electrophilic omega-3 PUFAs and their hydroxy precursors was evaluated by mass
spectrometry in neutrophils isolated from healthy subjects, both at baseline and upon stimulation with calcium ionophore.
For the clinical trial, participants were healthy adults 30–55 years of age with a reported EPA+DHA consumption of #
300 mg/day randomly assigned to parallel groups receiving daily oil capsule supplements for a period of 4 months
containing either 1.4 g of EPA+DHA (active condition, n = 24) or identical appearing soybean oil (control condition, n = 21).
Participants and laboratory technicians remained blinded to treatment assignments.
Results: 5-lypoxygenase-dependent endogenous generation of 7-oxo-DHA, 7-oxo-DPA and 5-oxo-EPA and their hydroxy
precursors is reported in human neutrophils stimulated with calcium ionophore and phorbol 12-myristate 13-acetate (PMA).
Dietary EPA+DHA supplementation significantly increased the formation of 7-oxo-DHA and 5-oxo-EPA, with no significant
modulation of arachidonic acid (AA) metabolite levels.
Conclusions: The endogenous detection of these electrophilic v-3 fatty acid ketone derivatives supports the precept that
the benefit of v-3 PUFA-rich diets can be attributed to the generation of electrophilic oxygenated metabolites that
transduce anti-inflammatory actions rather than the suppression of pro-inflammatory AA metabolites.
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Introduction
The dietary intake of v-3 polyunsaturated fatty acids (PUFAs)
provides a significant reduction in adverse cardiovascular events
and death [1–4]. Thus, the American Hearth Association and the
European Society of Cardiology recommend a daily dose of
approximately 1 g for secondary prevention [5]. v-3 PUFAs are
also effective in reducing the inflammatory phenotype in other
chronic degenerative diseases and acute events [2,6–8].
Among the proposed mechanisms of action through which v-3
PUFAs mediate clinical benefits, the formation of bioactive
oxygenated metabolites may be the most relevant. The enzymes
cyclooxygenase-2 (Cox-2) and lipoxygenases (LOs) in part sustain
the onset of inflammation by converting the v-6 PUFA
arachidonic acid (AA) into pro-inflammatory eicosanoids. These
oxygenases also convert v-3 PUFAs into bioactive lipid mediators
that promote the resolution of inflammation [8–11]. Recently, the
link between dietary intake of v-3 PUFAs and the formation of
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oxygenated derivatives has been explored showing a positive
correlation [12–19].
Among oxygenated PUFAs, electrophilic a,b-unsaturated
ketone derivatives are of interest because they a) are end-products
of hydroxylated fatty acid metabolism, b) display reversible
electrophilic reactivity with nucleophilic protein targets via
Michael addition reaction and c) modulate the activity of critical
inflammatory and host defense signaling pathways [20]. In this
regard, electrophilic PUFAs activate the Nrf2-dependent anti-
oxidant response, are partial agonists of the nuclear lipid receptor
PPARc, and suppress pro-inflammatory NF-kB signaling at
multiple levels [9,21–23]. Recently, a method has been developed
for the mass spectrometric detection and quantification of
electrophilic fatty acids, based on the use of the b-mercaptoethanol
(BME) as nucleophilic bait [24]. Its use in profiling electrophilic
fatty acid generation by activated macrophages led to the
discovery of Cox-2-dependent generation of 13- and 17-oxo-
derivatives of docosahexaenoic (DHA) and docosapentaenoic acid
(DPA)[9]. These electrophilic ketone derivatives mediate pleitropic
anti-inflammatory actions via modulation of transcriptional
regulatory protein function thus representing a new class of
endogenous lipid mediators.
Neutrophils are the most abundant white blood cells and, as
early responders to bacterial infections, are critical in shaping the
inflammatory milieu by releasing AA-derived 5-LO metabolites
including leukotriene B4 (LTB4), 5-hydroxy-eicosatetraenoic acid
(5-OH-ETE) and 5-oxo-ETE [25,26]. The formation of electro-
philic 5-oxo-EPA by 5-LO in neutrophils supplemented with EPA
antagonizes the pro-inflammatory actions of AA-derived metab-
olites [27]. Of note, the endogenous generation of 5-oxo-EPA and
other electrophilic a,b-unsaturated ketone derivatives of v-3
PUFAs has not been reported, most likely because of their facile
Michael addition to cellular and plasma nucleophiles, which
makes it difficult to detect these species in ‘‘free form’’ by
traditional organic and/or solid phase extraction methods.
Herein, the endogenous formation of electrophilic a,b-unsatu-
rated ketone derivatives of DHA, EPA and DPA is reported in
neutrophils isolated from healthy subjects. Specifically, 5-LO-
dependent generation of 7-oxo-DHA, 7-oxo-DPA, 5-oxoEPA and
their hydroxy precursors is reported. Moreover, the effects of EPA
and DHA consumption at a clinically-relevant dose (1.4 g/day) on
the production of these v-3 PUFA ketone derivatives was
evaluated in healthy human subjects participating in a random-
ized, placebo-controlled clinical trial. There was a significant
increase in levels of electrophilic v-3 PUFA ketone derivatives in
neutrophils under both basal and activated conditions, with no
significant change in AA-derived metabolites. It is proposed that
these reactive products transduce the salutary actions of v-3
PUFAs by modifying the activity of electrophile-sensitive tran-
scription factors that regulate the expression of inflammatory and
metabolic-related genes. This report follows CONSORT guide-
lines for clinical trials [28].
Materials and Methods
Ethics statement
All subjects recruited for the first part of the work provided
written informed consent, as approved by the University of
Pittsburgh Investigational Review Board (IRB #PRO07040037).
For the randomized clinical trial (ClinicalTrials.gov
#NCT00663871) ethics oversight was provided by the University
of Pittsburgh Human Subjects IRB and an expert external
monitor.
Materials
The following lipid standards were purchased from Cayman
Chemical: 5-oxo-6E,8Z,11Z,14Z-eicosatetraenoic-6,8,9,11,12,14,15-
d7 acid (5-oxoETE-d7, $99% deuterated product), 17-oxo-
4Z,7Z,10Z,13Z,15E,19Z-docosahexaenoic acid (17-oxo-DHA, $
98%), 17-oxo-7Z,10Z,13Z,15E,19Z-docosapentaenoic acid (17-oxo-
DPA, $98%), (6)13-hydroxy-4Z,7Z,10Z,14E,16Z,19Z-docosahex-
aenoic acid (13-OH-DHA, .98%), (6)7-hydroxy-4Z,8E,10Z,13Z,
16Z,19Z-docosahexaenoic acid (7-OH-DHA, .98%), 5-oxo-
6E,8Z,11Z,14Z-eicosatetraenoic acid (5-oxoETE, .95%), 5S-hy-
droxy-6E,8Z,11Z,14Z-eicosatetraenoic acid (5-OH-ETE, .98%),
(6)-5-hydroxy-6E,8Z,11Z,14Z,17Z-eicosapentaenoic acid (5-OH-
EPA, .98%). Docosahexaenoic acid (DHA, .99%) and docosa-
pentaenoic acid (DPA,.99%) were purchased from NuCheck Prep,
Inc.
Isolation of neutrophils
The blood of healthy adult volunteers was collected in EDTA-
coated tubes and layered over an equal volume of Polymorphprep
(Axis-Shield). Neutrophils were isolated by one-step density
gradient centrifugation following manufacturer’s instructions
(http://www.axis-shield-density-gradient-media.com). Residual
erythrocytes were lysed by resuspending pellets at 5uC in H2O
for 30 sec, followed by addition of one vol 0.3 M NaCl. Cells were
centrifuged, resuspended in Hanks’ Balanced Salt Solution (HBSS)
supplemented with 1.2 mM CaCl2 and 0.811 mM MgSO4,
counted using a hemocytometer and neutrophil concentrations
adjusted to 206106 cells/ml.
Neutrophil stimulation and sample collection
Neutrophils were stimulated with A23187 (5 mM) or phorbol
myristate acetate (PMA, 2 mM) and incubated at 37uC for the
indicated times. Time 0 was collected before the stimulus was
added. Where indicated, DHA or DPA was added before the
stimulus at a final concentration of 30 mM. For inhibition
experiments, the 5-LO activating protein (FLAP) inhibitor MK-
886 was added at a final concentration of 500 nM [29], cells were
incubated 15 min at 37uC and stimulated as indicated. Samples
(100 ml) were collected at the indicated time points and centrifuged
at 4uC. The pellet was resuspended in 20 ml 50 mM phosphate
buffer, pH 7.4, snap frozen in liquid nitrogen and stored at -80uC
until further processing.
Capture of electrophilic fatty acid derivatives by BME
reaction and LC-MS/MS analysis
For detection of PUFA electrophilic derivatives, samples were
treated with 500 mM BME in presence of the internal standard 5-
oxo-ETE-d7 (final concentration 2.5 ng/ml) for 2 h at 37uC
[9,24]. Reactions were stopped by addition of 4 volumes cold
acetonitrile/1% formic acid, protein precipitates were removed by
centrifugation and supernatants collected for mass spectrometry
(MS) analysis. Fatty acids were resolved by reversed-phase high
performance liquid chromatography (RP-HPLC) using
15062 mm C18 Luna column (3 mm, Phenomenex) with a flow
rate of 250 ml/min using the following gradient conditions: hold at
35% B for 3 min, increase to 90% B during 43 min, increase to
100% B and hold for 6 min to then re-equilibrate at initial
conditions for 8 min. Analysis and quantification of BME adducts
of electrophilic fatty acids and free fatty acids OH-derivatives were
performed in the negative ion mode using an API-5000 (Applied
Biosystems/MDS Sciex) mass spectrometer equipped with an
electrospray ionization (ESI) probe in multiple reaction monitoring
(MRM) scan mode. The following settings were used: declustering
Generation of Anti-Inflammatory v-3 PUFAs by Activated Neutrophils
PLOS ONE | www.plosone.org 2 April 2014 | Volume 9 | Issue 4 | e94836
potential -50 V and collision energy -17 V. Zero grade air was
used as source gas, and N2 was used in the collision chamber. Data
were acquired and analyzed using Analyst 1.4.2 software (Applied
Biosystems, Framingham, MA).
Electrophilic fatty acid quantification and accurate mass
determinations
Standard curves were generated using 5-OH-EPA, 5-OH-ETE,
7-OH-DHA and the BME addition products of 17-oxo-DHA, 17-
oxo-DPA and 5-oxo-ETE using 5-oxo-ETE-d7 as internal
standard by plotting area ratio (analyte/IS) vs concentration ratio
(analyte/IS). High resolution mass determination and structural
characterization was performed on a HPLC-coupled Velos
Orbitrap hybrid mass spectrometer (Thermo Fisher Scientific,
Bremen, Germany) equipped with a heated electrospray ionization
(HESI) probe.
In vitro enzymatic oxidation of omega-3 fatty acids
Human recombinant 5-lipoxygenase (0.7 U, Cayman Chemi-
cals) was added to 50 mM Tris-HCl buffer, pH 7.4, containing
2 mM CaCl2 and 2 mM ATP, in the presence of 30 mM DHA or
DPA. Reaction mixtures were incubated at 37uC for 15 min and
reactions stopped by adding two volume acetonitrile chilled to
5uC. Enzyme was removed by precipitation, and supernatants
were analyzed by LC-MS/MS.
Figure 1. CONSORT flowchart of the study AHAB-2. Patients recruited for the present substudy are indicated at the bottom of the flow
diagram under the heading ‘‘Analysis’’.
doi:10.1371/journal.pone.0094836.g001
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Figure 2. Generation of 7-oxo-DHA and 7-oxo-DPA by neutrophils supplemented with DHA or DPA and stimulated with calcium
ionophore. Freshly isolated neutrophils were supplemented with 30 mM DHA (A–D) or DPA (E–G) and stimulated with calcium ionophore. Samples
were collected at 15 min and cell extracts were reacted with 500 mM BME for detection of electrophilic fatty acids. (A,E) Chromatograms were
acquired following the neutral loss of BME using the following transitions: 419.2 to 341.2(A) and 421.2 to 343.2 (E). Insets show mass spectra with
respective BME b-elimination due to in source fragmentation. (B,F) Product ion analysis of BME-oxo-DHA (m/z 419.2, B) and BME-oxo-DPA (m/z 421.2,
F); (C,G) MS/MS analysis of the free oxo-DHA (C) and oxo-DPA (G) generated by in-source fragmentation upon respective BME neutral loss; (D) MS/MS
analysis of 7-oxo-DHA synthetic standard; (H) chemical structure and fragmentation pattern of 7-oxo-DHA and 7-oxo-DPA. 7-oxo-DHA standard was
Generation of Anti-Inflammatory v-3 PUFAs by Activated Neutrophils
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Clinical trial design
The randomized clinical trial herein reported is a substudy of a
larger parent cross-sectional study: Adult Health and Behavior,
Phase 2 (AHAB-2). Participants to AHAB-2 were initially recruited
using mass mailing in the greater Pittsburgh metropolitan area
between June 2008 and August 2011. Participants were required
to be 30–54 years of age and employed at least 25 hours per week.
Exclusion criteria included atherosclerotic disease (e.g., myocardial
infarction or revascularization), history of psychosis (schizophrenia
or bipolar disorder), chronic hepatitis, chronic kidney disease,
chronic lung disease requiring daily drug treatment, stage 2
hypertension, alcohol consumption greater than 35 alcoholic
drinks per week and, in women, pregnancy or lactation. Persons
prescribed any cardiovascular, psychotropic, glucocorticoid, lipid-
lowering, insulin or weight-loss medications were also excluded, as
were those taking fish oil, algae, algal oil, or DHA supplements.
Individuals who completed AHAB2 were invited to be screened
for enrollment in a randomized and placebo-controlled trial of fish
oil supplementation. (See Figure 1, CONSORT flow chart.) The
additional exclusion criteria for the trial were allergy to fish and
estimated daily dietary consumption of EPA and DHA combined
greater than 300 mg/day. Eligible volunteers were assigned in an
allocation ratio of 1:1 to parallel groups receiving either daily fish
oil supplements or matching soybean oil placebo capsules for 4
months. Treatment assignment was randomized, utilizing a
computerized minimization algorithm considering gender, race
(Black, Non-black) and age stratum (,45, ./= 45) measured at
baseline. Fish oil supplementation consisted of two 1000 mg
capsules, with each capsule containing 500 mg EPA, 200 mg
DHA, 10 IU of vitamin E and mint flavor. Placebo supplemen-
tation consisted of two 1000 mg capsules of soybean oil, each also
containing 10 IU of vitamin E and mint flavor. Participants and
laboratory technicians remained blinded to treatment assignment.
The primary outcomes of the main clinical trial were circulating
markers of systemic inflammation; autonomic control of heart
rate; measures of cognitive functioning; and self-report, laborato-
ry-based, and interview-based measures of affect, hostility, anger,
impulsivity, and aggression (The protocol for this trial and
supporting CONSORT checklist are available as supporting
information; see Checklist S1 and Protocol S1). These data are
being prepared for publication separately. The trial is registered at
ClinicalTrials.gov (Evaluating the effects of omega-3 fatty acids on
heart disease and behavior; NCT00663871).
The current report describes the trial’s secondary outcomes
related to the clinical generation and dietary modulation of
electrophilic v-3 fatty acid derivatives. To this purpose, samples
were collected from a small subset of study participants recruited
between January 2010 and December 2011 (see Figure 1). Baseline
characteristics of the subpopulation used for the present study did
not differ from those of the whole study population (Table S1).
The sample size for this substudy was determined based on the
availability of resources to conduct the specialized laboratory
measures.
Analysis of red blood cells (RBC) fatty acid composition
For RBC fatty acid analysis, hemoglobin-free RBC ghost
membranes were prepared as previously described and stored at -
70uC until further use [30]. Lipids were extracted from RBC ghost
membranes [31] and fatty acid methyl esters (FAME) were
prepared using methanolic KOH reagent [32]. Diheptadecanoyl
lecithin (Matraya, Inc.) was used as an internal standard.
Quantitative determination of fatty acid distribution was per-
formed by capillary gas chromatography with flame ionization
detector (GC-FID) using a Hewlett-Packard capillary gas chro-
matograph (Model 5890 Series II) equipped with a hydrogen
flame ionization detector. The method used for the analysis has
been previously described [33].
Data analysis
The results are expressed as mean 6 standard error (SE).
Statistical analysis of pair wise comparison was done by applying
the non-parametric Mann–Whitney–Wilcoxon test using the
software StatView. A p-value,0.05 was considered statistically
significant.
Results
Generation of electrophilic a,b-unsaturated ketone
derivatives from DHA and DPA in human neutrophils
Freshly isolated human neutrophils were supplemented with
30 mM DHA or DPA and stimulated with calcium ionophore for
15 min. Cell extracts were treated with BME to capture
electrophilic species and analyzed by HPLC-MS/MS. When
neutrophils were supplemented with DHA, species displaying a
neutral loss of 78 amu revealed a major parent ion with m/z 419.2
corresponding to BME addition to oxo-DHA (m/z 341.2+78)
(Figure 2A). MS/MS analysis and accurate mass determination at
the 2 ppm level confirmed the atomic composition of the parent
and product ions (Figure 2A, B). Neutrophils supplemented with
DPA presented a major ion with m/z 421.2, corresponding to
BME addition to oxo-DPA that fragmented through the neutral
loss of BME (collision-induced gas phase b-elimination
reaction)(Figure 2E, F). For structural characterization, two
different methodological approaches were used: a) MS/MS
fragmentation of the ions generated from BME loss during in-
source fragmentation (in source b-elimination of BME) and b)
MS3 following the sequential loss of BME and fragmentation of
the resulting product ion. Both methods gave similar results,
although the overall efficiency and intensities obtained upon in-
source fragmentation were usually higher (Figure 2C, G).
Fragmentation of oxo-DHA (m/z 341.2) gave, in addition to the
non-specific ions corresponding to loss of water (m/z 323.2) and
loss of CO2 (m/z 297.2), two diagnostic fragment ions at m/z
201.2 and 243.2 (Figure 2C). These corresponded to the
fragmentation pattern of 7-oxo-DHA as further confirmed by
comparison with a synthetic standard (Figure 2D). Neutrophil-
derived oxo-DPA (m/z 343.2) presented a similar fragmentation
pattern that, in addition to the loss of water and CO2 (m/z 325.2
and 299.2, respectively), gave two diagnostic fragment ions at m/z
201.2 and 245.2 (Figure 2G, H), characteristic of 7-oxo-DPA.
Formation of di-oxygenated electrophilic derivatives of DHA and
DPA was also observed in neutrophils supplemented with the
respective omega-3 fatty acid precursors. In particular, the
formation of oxo-OH-DHA was observed in neutrophils supple-
mented with DHA. This species reacted with BME, giving an
adduct with m/z of 435.2 and, after fragmentation-induced
neutral loss of BME, an ion with m/z 357.2 (Figure 3A, B). A
similar chromatographic profile was observed for DPA-derived
oxo-OH-derivatives in DPA-supplemented samples which gave an
adduct with m/z 437.2 characterized by the major neutral loss of
enzymatically synthesized by incubating 20 mM 7-OH-DHA with 3a-hydroxysteroid dehydrogenase in the presence of 100 mM NAD+ for 10 min at
37uC.
doi:10.1371/journal.pone.0094836.g002
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Figure 3. Generation of OH-oxo-DHA and OH-oxo-DPA by neutrophils supplemented with DHA or DPA and stimulated with
calcium ionophore. Freshly isolated neutrophils were supplemented with 30 mM DHA (A-D) or DPA (E-H) and stimulated with calcium ionophore.
Samples were collected at 15 min and cell extracts were reacted with excess BME for detection of electrophilic fatty acid derivatives. (A, E)
Chromatograms showing elution of ions with m/z 435.2 (A) and 437.2 (E) and their respective BME b-elimination due to in source fragmentation
(insets). (B, F) Product ion analysis of BME-OH-oxo-DHA (m/z 435.2, B) and BME-OH-oxo-DPA (m/z 437.2, F); (C, G) MS/MS analysis of the free OH-oxo-
DHA (C) and OH-oxo-DPA (G) generated by in-source fragmentation upon respective BME neutral loss; (D, H) proposed chemical structure and
fragmentation pattern of 17-OH-7-oxo-DHA (D) and 17-OH-7-oxo-DPA (H).
doi:10.1371/journal.pone.0094836.g003
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BME upon fragmentation and the detection of the free oxo-OH
fatty acid with m/z 359.2 (Figure 3E, F). Accurate mass
determination and MS/MS analysis of the in-source generated
ion corresponding to the free fatty acid revealed the formation of a
diagnostic fragment ion with m/z 259.1 from oxo-OH-DHA
(elemental composition C16H19O3) and 261.1 from oxo-OH-DPA
(elemental composition C16H21O3) (Figure 3C, G). These
fragments contained the oxo- and the carboxy-group, inferring a
specific fragmentation induced by the presence of an OH group at
C-17 (Figure 3D, H).
For sensitive quantification of electrophilic a,b-unsaturated
ketone derivatives, MS analysis was performed following the loss of
BME in multiple reaction monitoring (MRM) mode [24]. The
generation of 7-oxo-DHA, 7-oxo-DPA and 5-oxo-EPA was
measured over time in neutrophils stimulated with calcium
ionophore. Extents of ketone metabolite formation were greatest
at 15 min and afterwards returned towards basal levels (Figure 4).
To further investigate the endogenous formation of v-3 fatty acid-
derived electrophilic species after protein kinase C (PKC)
activation, phorbol myristate acetate (PMA) was added in the
absence of external fatty acid supplementation. As reported in
Figure 5, neutrophils stimulated with PMA generated 5-oxo-EPA,
7-oxo-DHA and 7-oxo-DPA and their hydroxy precursors. All of
these species co-eluted with those generated by calcium iono-
phore-stimulated neutrophils and with available synthetic stan-
dards.
5-lipoxygenase is required for generation of 7-oxo-DHA
and 7-oxo-DPA by neutrophils
To assess whether 5-LO was required for the generation of the
electrophilic 7-oxo-DHA and 7-oxo-DPA, neutrophils were
pretreated with the 5-LO specific inhibitor MK-886 and
formation of DHA- and DPA-oxo-derivatives and their hydroxy
precursors was evaluated after stimulation with calcium iono-
phore. Inhibition of 5-LO completely suppressed the formation of
7-oxo-DHA and 7-oxo-DPA and their hydroxy precursors to an
extent similar to what was observed for inhibition of 5-oxo-EPA
and 5-OH-EPA generation (Figure 5). Product analysis of the in
vitro reaction of human recombinant 5-LO with DHA and DPA
showed that 5-LO primarily generates the 7-OH-derivative from
both substrates, supporting that this enzyme mediates the first
biosynthetic step in the formation of electrophilic 7-oxo-derivatives
from 22 carbon PUFAs (Figure 6).
Dietary intake of EPA and DHA increases the formation of
v-3 PUFA a,b-unsaturated ketone derivatives in
neutrophils under basal conditions and upon activation
It was next investigated whether the administration of clinically-
relevant EPA and DHA doses that are recommended for
cardiovascular prevention [5] modulates the formation of electro-
philic a,b-unsaturated ketone derivatives by neutrophils. To this
purpose 45 healthy volunteers with ,300 mg/day consumption of
EPA and DHA received either fish oil (1 g/day EPA and 0.4 g/
day DHA) or control administration of 2 g/day soybean oil.
Participants in the two treatment groups did not differ in biometric
characteristics, baseline dietary EPA+DHA consumption and
baseline red blood cell (RBC) levels of EPA+DHA (Table 1).
Regarding the use of aspirin or other nonsteroidal anti-inflamma-
tory drugs (NSAIDs) at baseline, 2 persons reported taking aspirin
(one in the control group and one in the fish oil group) and 16
persons reported other NSAIDs (7 in the control group and 9 in
the fish oil group).
At the completion of the four month treatment period, fasting
blood samples were obtained. Neutrophils were isolated from the
freshly-drawn blood and endogenous levels of 5-oxo-EPA, 7-oxo-
DHA, 7-oxo-DPA, 5-oxo-ETE and their hydroxy precursors were
measured at basal conditions and 15 min after stimulation with
calcium ionophore. The supplementation of EPA and DHA
significantly increased the levels of oxygenated EPA and DHA
derivatives in neutrophils, in particular 5-oxo-EPA and 7-oxo-
DHA, both under basal conditions and after stimulation
(Figure 7A). Mean 7-oxo-DPA levels slightly increased in the fish
oil group, but this was not statistically significant. Dietary EPA+
DHA supplementation increased 5-OH-EPA and 7-OH-DHA,
precursors to electrophilic metabolites, to a lesser extent than
electrophilic ketone derivatives (Figure 7B). Only 7-OH-DPA (and
7-OH-DHA after stimulation) accumulated to significantly greater
levels in the fish oil group before and after calcium ionophore
stimulation, inferring that further oxidation to the bioactive a,b-
unsaturated ketone product was less efficient compared to 5-OH-
EPA and 7-OH-DHA. The analysis of AA-derived 5-oxo-ETE, 5-
OH-ETE and LTB4 metabolites under basal conditions and after
Figure 4. Time course of the generation of electrophilic 7-oxo-DHA, 7-oxo-DPA and 5-oxo-EPA by activated neutrophils. Freshly
isolated neutrophils from three independent healthy subjects were stimulated with calcium ionophore, samples were collected at the indicated time
points and cell extracts were reacted with 500 mM BME for quantification of selected electrophilic a,b-unsaturated omega-3-derived fatty acids by
LC-MS/MS.
doi:10.1371/journal.pone.0094836.g004
Generation of Anti-Inflammatory v-3 PUFAs by Activated Neutrophils
PLOS ONE | www.plosone.org 7 April 2014 | Volume 9 | Issue 4 | e94836
neutrophil activation revealed no significant differences between
the control and the fish oil group (Figure S1).
Discussion
The generation of electrophilic a,b-unsaturated ketone deriva-
tives of the v-3 fatty acids EPA, DHA and DPA was mediated by
neutrophils isolated from healthy subjects. The enzyme 5-LO
catalyzed the synthesis of the hydroxy precursors 5-OH-EPA, 7-
OH-DHA and 7-OH-DPA which were then oxidized to
electrophilic a,b-unsaturated ketone derivatives by cellular dehy-
drogenases (Figure 8). The detection and quantification of these
low molecular weight thiol-reactive signaling mediators by mass
spectrometry was facilitated by the use of the nucleophilic BME as
an electrophile-trapping bait. The supplementation of human
volunteers with EPA and DHA for 4 months enhanced the
generation of these bioactive neutrophil products under both basal
conditions and after neutrophil activation. Notably, these condi-
tions did not significantly impact the formation of pro-inflamma-
tory AA-derived eicosanoids.
A transformative insight from this work is the observation that a
diet rich in v-3 EPA and DHA increases the formation of anti-
inflammatory electrophilic a,b-unsaturated ketone fatty acid
derivatives by neutrophils. Current understanding supports that
electrophilic fatty acid oxygenation products mediate potent anti-
inflammatory and cytoprotective signaling actions via both
receptor-dependent and –independent mechanisms [9,20]. These
species signal by undergoing covalent Michael addition with
nucleophilic targets such as cysteine and histidine residues of
proteins. By reversibly adducting susceptible targets, a property
defined by structural location and chemical reactivity, electrophilic
PUFA derivatives modulate signaling pathways involved in the
Figure 5. Endogenous generation of 5-oxo-EPA, 7-oxo-DHA, 7-oxo-DPA and their hydroxy precursors by activated neutrophils.
Freshly isolated neutrophils were stimulated for 15 min with the indicated treatment, cell extracts were reacted with 500 mM BME and lipid
derivatives were measured by LC-MS/MS in MRM mode. (A) BME adducts of 5-oxo-EPA, 7-oxo-DHA and 7-oxo-DPA were measured following loss of
BME. (B) For the measurement of non-electrophilic hydroxy derivatives the following transitions were used: 317.2/299.2 (5-OH-EPA), 343.2/281.2 (7-
OH-DHA), 345.2/327.2 (7-OH-DPA). Where available, chromatograms of synthetic standards are also reported. 7-oxo-DHA and 5-oxo-EPA standards
were enzymatically synthesized by incubating 20 mM of OH-precursors with 3a-hydroxysteroid dehydrogenase, in presence of 100 mM NAD+ for
10 min at 37u. Insets show a magnified view of chromatograms. Std, standard.
doi:10.1371/journal.pone.0094836.g005
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Figure 6. In vitro synthesis of 7-OH-DHA and 7-OH-DPA from DHA and DPA precursors by human recombinant 5-LO. Human
recombinant 5-LO was incubated with 30 mM DHA (A-C) or DPA (D-E) in the presence of 2 mM ATP at 37uC for 15 min and ion product formation was
analyzed by LC-MS/MS using high resolution mass spectrometry (Velos/Orbitrap (A, D)). For 7-OH-DHA the elution profile of the synthetic standard is
reported as grey line in the inset (A). (B, E) Product ion spectra, chemical structures and interpretation of fragmentation upon collision induced
dissociation. (C) Mass spectrum of 7-OH-DHA chemical standard.
doi:10.1371/journal.pone.0094836.g006
Table 1. Characteristics of clinical trial study population.
Control Treatment p-valuea
N 21 24
Gender (% female) 67% 67% 0.99
Age (years) 43.366.9 44.867.8 0.51
BMI (Kg/m2) 27.464.9 28.466.3 0.58
Dietary EPA+DHA (mg/day) 97666 102670 0.83
Baseline EPA+ DHA in RBCs (mole %) 2.5761.41 2.8561.35 0.47
Post-supplementation EPA+ DHA in RBCs (mole %) 2.2461.09 4.0561.79 ,.001
Continuous variables are reported as mean 6 standard deviation.
BMI, body mass index; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid; RBCs, red blood cells.
abased on Chi-square statistic for gender and t-test for other measures.
doi:10.1371/journal.pone.0094836.t001
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control of metabolic and inflammatory status of the cell. For
example, suppression of pro-inflammatory NF-kB-regulated gene
expression, partial agonist activity for the peroxisome proliferators-
activated receptor gamma (PPARc) and activation of Nrf2-
regulated phase II gene expression account for many of the
actions of these electrophilic v-3 PUFA metabolites
[9,20,21,23,34].
In vitro studies show that 5-oxo-EPA is generated by
neutrophils after supplementation with EPA via consecutive
enzymatic reactions catalyzed by 5-LO and 5-hydroxyeicosanoid
dehydrogenase (5-HEDH) [27]. Herein, basal and dietary-
enhanced levels of 7-oxo-DHA and 7-oxo-DPA and their
respective hydroxy precursors are reported for the first time.
Basal levels of these species were detected in neutrophils isolated
from healthy subjects, and these levels increased after neutrophil
activation by either calcium ionophore or PMA in the absence of
in vitro or clinical v-3 PUFA supplementation. The formation of
these species in neutrophils was abolished upon treatment with the
5-lipoxygenase activating protein (FLAP) inhibitor MK-866,
revealing a role for 5-LO in 7-OH-DHA and 7-OH-DPA
synthesis. 5-HEDH, which displays broad substrate selectivity, is
a likely candidate for the catalysis of 7-OH-DHA and 7-OH-DPA
oxidation to a,b-unsaturated ketone derivatives [35]. Notably, 5-
oxo-EPA reached much higher levels compared to oxo-DHA and
oxo-DPA, despite the fact that levels of the hydroxy precursors
were of the same order of magnitude (Figure 7). This suggests that
5-OH-EPA is converted into the ketone derivative more efficiently
than 7-OH-DHA and 7-OH-DPA. These electrophilic products
reached a maximum concentration 15 min after neutrophil
stimulation and returned to baseline levels at later times
(Figure 4). This kinetic profile for neutrophil generation of
electrophilic fatty acids contrasts with activated macrophages,
where Cox-2-dependent formation of 13- and 17-oxo-derivatives
of DHA and DPA reached maximum levels 6 to 8 hr after
stimulation [9]. The differing kinetics and electrophilic product
distribution for neutrophils compared to macrophages reflect
cellular differences in fatty acid oxygenation specificity and
mechanisms of expression and regulation of 5-LO and Cox-2.
In addition to mono-oxygenated EPA and DHA products,
chromatographic peaks corresponding to di-OH derivatives were
detected in neutrophils that could correspond to LTB5 and other
omega-hydroxylation derivatives (Figure 8). These species are of
interest, but the low levels detected precluded any further
characterization and quantification. Tri-OH species (termed
lipoxins and resolvins) were undetectable. Importantly, high levels
of electrophilic ions displaying m/z values corresponding to oxo-
OH-EPA and oxo-OH-DHA were detected in fatty acid-
supplemented neutrophils (Figure 3). Although these higher levels
of electrophilic species may be attributed to the increased
sensitivity of detection of oxygenated fatty acids by the BME-
based analytical approach, the abundance of combined keto/
hydroxy metabolites highlights the potential significance of these
electrophilic species as electrophilic signaling mediators that can
modulate adaptive gene expression during inflammation. The
MS/MS fragmentation pattern of these species and high
resolution mass determinations at the 2 ppm level indicated that
the second OH-group was at carbon 17, inferring a 15-LO-
catalyzed oxygenation product [36]. Since neutrophils do not
express 15-LO, the 17-hydroxy products detected herein may arise
from low levels of contaminating eosinophils present after
Polymorphprep isolations [37].
The dietary supplementation of omega-3 PUFAs provides
significant health benefits, by reducing the risk of cardiovascular
mortality and sudden cardiac death [1]. There is also an associated
reduction of plasma triglyceride levels, reduced risk of atrial
fibrillation [38] and a variety of local and systemic anti-inflamma-
tory actions of v-3 PUFAs both in vitro and in vivo [39–42]. The
suppression of AA-derived pro-inflammatory eicosanoids and an
increased generation of bioactive oxygenated metabolites are the
two most relevant mechanisms through which v-3 PUFAs have
been proposed to exert anti-inflammatory actions. While there is a
positive correlation between dietary consumption of EPA and DHA
and formation of oxygenated metabolites [13,15,16,18,19,43], the
effects of EPA and DHA consumption on AA metabolites levels are
controversial and likely dependent on v-3 PUFA dosing regimens.
Several studies have evaluated the impact of dietary v-3 PUFAs on
the production of AA-derived eicosanoids and modulation of
membrane lipid composition by lowering v-6 / v-3 ratios
[12,13,15,16,18,19,44–47]. A decrease of AA-metabolite genera-
tion in human plasma as well as in activated neutrophils and
Figure 7. Dietary modulation of 5-oxo-EPA, 7-oxo-DHA and 7-
oxo-DPA generation and their hydroxy precursors by neutro-
phils. Formation of 5-oxo-EPA, 7-oxo-DHA, 7-oxo-DPA (A) and their
hydroxy precursors (B) was measured in freshly isolated neutrophils
under basal conditions and after stimulation with calcium ionophore in
healthy subjects consuming either control soybean oil (white bars) or a
fish oil-supplemented diet (black bars). Neutrophils were stimulated for
15 min with calcium ionophore, cell extracts were reacted with 500 mM
BME and the BME-adducted electrophilic oxo-fatty acids as well as non-
electrophilic hydroxy fatty acids were quantified by LC-MS/MS. Data are
expressed as mean 6 SE, n = 21 and 24 for control and fish oil,
respectively. The Mann–Whitney U test was used for pair wise
comparisons of patients groups. **, p-value,0.005.
doi:10.1371/journal.pone.0094836.g007
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Figure 8. Enzymatic pathways leading to the formation of long chain PUFAs oxidized derivatives in activated neutrophils.
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macrophages is typically observed upon administration of high
concentrations (,5 g/day) of v-3 PUFAs [13,43,46]. In the current
study, no significant differences in the basal content or activated
neutrophil formation of AA-derived eicosanoids was observed in
both control and fish oil-supplemented groups (Figure S1).
The current data support the precept that the biochemical basis
for the beneficial actions of dietary v-3 PUFAs is the increased
synthesis of bioactive oxygenated species rather than the
suppression of pro-inflammatory AA-derived products. Further-
more, increased baseline levels of anti-inflammatory and electro-
philic v-3 PUFA derivatives, as reported herein for the fish oil-
supplemented group, may limit inflammation and tissue damage.
In this regard, both receptor-dependent and –independent
signaling actions of fatty acid electrophiles would result in
transcriptional suppression of genes involved in inflammatory
propagation reactions and the activation of cytoprotective
mechanisms [9,40,41,48].
With regards to the clinical trial herein presented, some study
limitations should be acknowledged. First, measurements were not
obtained at baseline, before the beginning of dietary supplemen-
tation. Therefore, although unlikely due to randomization, the
possibility that the observed differences between the two groups
existed irrespective of fish oil supplementation cannot be excluded.
Second, the study had a small sample size. Nevertheless,
statistically significant differences were observed between the two
study groups, in particular when analyzing oxidized derivatives of
EPA and DHA. Finally, as these measures were obtained in the
specified ex vivo preparations, it remains to be determined
whether increased intake of EPA and DHA would affect
electrophilic v-3 fatty acid ketone derivative generation in vivo.
Despites these limitations, findings herein reported are of great
significance as they provide the first evidence from a controlled
clinical trial that customary doses of dietary EPA and DHA
increases the generation of electrophilic oxygenated derivatives
with known anti-inflammatory properties.
In summary, we report the formation and dietary modulation of
oxygenated electrophilic v-3 PUFA ketone derivatives in neutro-
phils from healthy subjects. These findings support a role for
dietary v-3 PUFAs in exerting salutary cell signaling effects
through the formation of electrophilic oxygenated derivatives.
Furthermore, the results highlight the importance of neutrophils as
first responders to sites of injury and inflammation and the
function of electrophilic fatty acids in limiting the progression of
inflammation and induction of tissue-protective responses.
Supporting Information
Figure S1 Endogenous generation of AA metabolites by
neutrophils from subjects on a fish oil diet compared to
the control group. 5-oxo-ETE, 5-OH-ETE and LTB4 were
measured in freshly isolated neutrophils under basal conditions
and upon stimulation with calcium ionophore in healthy subjects
consuming either control soybean oil (white bars) or a fish oil-
supplemented diet (black bars). Neutrophils were stimulated for
15 min with calcium ionophore, cell extracts were reacted with
BME and electrophilic fatty acids were quantified by LC-MS/MS.
Data are expressed as mean 6 SE, n= 21 and 24 for control and
fish oil, respectively. The Mann–Whitney U test was used for pair-
wise comparisons of patient groups. No significant differences were
observed.
(TIF)
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